Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method.
D000328:Adult; D000368:Aged; D002852:Chromatography, Ion Exchange; D003404:Creatinine / Q000378:metabolism; D003561:Cytarabine; D003973:Diatrizoate; D005260:Female; D005492:Folic Acid; D006493:Heparin; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008722:Methods; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism; D008875:Middle Aged; D009369:Neoplasms / Q000378:metabolism*; D010084:Oxidation-Reduction; D011196:Potassium Permanganate; D013050:Spectrometry, Fluorescence; D013997:Time Factors; D014223:Triamterene; D014316:Tritium; D014364:Tryptophan; D014414:Tungsten
D011196:Potassium Permanganate; D003561:Cytarabine; D014316:Tritium; D003973:Diatrizoate; D014364:Tryptophan; D006493:Heparin; D005492:Folic Acid; D003404:Creatinine; D014414:Tungsten; D014223:Triamterene; D008727:Methotrexate